1921
Volume 91, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Haiti is one of two remaining malaria-endemic countries in the Caribbean. To decrease malaria transmission in Haiti, primaquine was recently added to the malaria treatment public health policy. One limitation of primaquine is that, at certain doses, primaquine can cause hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PDd). In this study, we genotyped two mutations (A376G and G202A), which confer the most common G6PDd variant in West African populations, G6PDd A−. We estimated the frequency of G6PDd A− in a sample of febrile patients enrolled in an on-going malaria study who represent a potential target population for a primaquine mass drug administration. We found that 33 of 168 individuals carried the G6PDd A− allele (includes A− hemizygous males, A− homozygous or heterozygous females) and could experience toxicity if treated with primaquine. These data inform discussions on safe and effective primaquine dosing and future malaria elimination strategies for Haiti.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.14-0053
2014-08-06
2017-09-23
Loading full text...

Full text loading...

/deliver/fulltext/14761645/91/2/412.html?itemId=/content/journals/10.4269/ajtmh.14-0053&mimeType=html&fmt=ahah

References

  1. Beutler E, Kuhl W, Vives-Corrons JL, Prchal JT, , 1989. Molecular heterogeneity of glucose-6-phosphate dehydrogenase A. Blood 74: 25502555.
  2. Ruwende C, Hill A, , 1998. Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med (Berl) 76: 581588.[Crossref]
  3. White NJ, Qiao LG, Qi G, Luzzatto L, , 2012. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J 11: 418.[Crossref]
  4. Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI, , 2013. G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol 81: 133201.[Crossref]
  5. WHO Evidence Review Group, 2012. The Safety and Effectiveness of Single Dose Primaquine as a P. Falciparum Gametocytocide. Bangkok: World Health Organization.
  6. WHO, 2012. World Malaria Report. Geneva: World Health Organization.
  7. Von Fricken ME, Weppelmann TA, Eaton WT, Alam MT, Carter TE, Schick L, Masse R, Romain JR, Okech BA, , 2014. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Ouest and Sud-Est departments of Haiti. Acta Tropica 135: 6266.[Crossref]
  8. Carter TE, Warner M, Mulligan CJ, Existe A, Victor YS, Memnon G, Boncy J, Oscar R, Fukuda MM, Okech BA, , 2012. Evaluation of dihydrofolate reductase and dihydropteroate synthetase genotypes that confer resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum in Haiti. Malar J 11: 275.[Crossref]
  9. Verrelli BC, McDonald JH, Argyropoulos G, Destro-Bisol G, Froment A, Drousiotou A, Lefranc G, Helal AN, Loiselet J, Tishkoff SA, , 2002. Evidence for balancing selection from nucleotide sequence analyses of human G6PD. Am J Hum Genet 71: 11121128.[Crossref]
  10. Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G, Drousiotou A, Dangerfield B, Lefranc G, Loiselet J, Piro A, Stoneking M, Tagarelli A, Tagarelli G, Touma EH, Williams SM, Clark AG, , 2001. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 293: 455462.[Crossref]
  11. Mannucci A, Sullivan KM, Ivanov PL, Gil P, , 1994. Forensic application of a rapid and quantitative DNA sex test by amplification of the X-Y homologous gene amelogenin. Int J Legal Med 106: 190193.[Crossref]
  12. Beutler E, Yeh M, Fairbanks VF, , 1962. The normal human female as a mosaic of X-chromosome activity: studies using the gene for G-6-PD-deficiency as a marker. Proc Natl Acad Sci USA 48: 916.[Crossref]
  13. Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E, , 2012. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the “old” and update of the new mutations. Blood Cells Mol Dis 48: 154165.[Crossref]
  14. Clark TG, Fry AE, Auburn S, Campino S, Diakite M, Green A, Richardson A, Teo YY, Small K, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Sabeti P, Kwiatkowski DP, Rockett KA, , 2009. Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. Eur J Hum Genet 17: 10801085.[Crossref]
  15. Jalloh A, Jalloh M, Gamanga I, Baion D, Sahr F, Gbakima A, Willoughby VR, Matsuoka H, , 2008. G6PD deficiency assessment in Freetown, Sierra Leone, reveals further insight into the molecular heterogeneity of G6PD A. J Hum Genet 53: 675679.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.14-0053
Loading
/content/journals/10.4269/ajtmh.14-0053
Loading

Data & Media loading...

  • Received : 21 Jan 2014
  • Accepted : 13 Apr 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error